Association between local immune cell infiltration, mismatch repair status and systemic inflammatory response in colorectal cancer

• Published in: Journal of Translational Medicine
• Main Authors: Gunnarsson, Ulf, Strigård, Karin, Edin, Sofia, Gkekas, Ioannis, Mustonen, Harri, Kaprio, Tuomas, Böckelman, Camilla, Hagström, Jaana, Palmqvist, Richard, Haglund, Caj
• Format: Article in Journal/Newspaper
• Language: English
• Published: Umeå universitet, Kirurgi 2020
• Subjects: Colorectal cancer; Local immune response; Miscrosatellite instability; Mismatch repair; Systematic inflammatory response; Cancer and Oncology; Cancer och onkologi; Sigrid; Northern Sweden
• Online Access: http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-170488; https://doi.org/10.1186/s12967-020-02336-6

BACKGROUND: Systemic inflammatory response in colorectal cancer (CRC) has been established as a prognostic factor for impaired cancer-specific survival, predominantly in patients with right-sided tumors. On the other hand, defective mismatch repair (dMMR) tumors, primarily located in the right colon, are known to have favorable survival and dense local immune infiltration. The aim of this study was to see if there is any form of relationship between these seemingly diverse entities. METHODS: Complete clinical and long-term survival data were retrieved for 316 CRC patients operated at Helsinki University Hospital between the years 1998 and 2003. Tissue microarrays were prepared from surgical specimens and further processed and analyzed for local immune cell infiltration using multispectral imaging with a Vectra quantitative pathology imaging system and Inform software. Multiplex immunohistochemistry was applied using antibodies against CD66b, CD8, CD20, FoxP3, CD68 and pan-Cytokeratin. After exclusions, data on immune infiltration were available for 275 patients. Mismatch repair status was determined by immunohistochemistry. RESULTS: CRP was seen to be an independent predictor of cancer-specific survival but not overall survival in uni- and multivariable (HR 1.01 (1.00-1.02); p = 0.028) analyses of non-irradiated patients. There was no significant difference in CRP according to mismatch repair status, but all cases (n = 10) with CRP ≥ 75 mg/l had proficient mismatch repair (pMMR). There was a significant negative correlation between intratumor stromal infiltration by T-regulatory FOXP3+ cells and CRP (p = 0.006). There was significantly lower intratumor stromal infiltration by FOXP3+ cells (p = 0.043) in the right colon compared to the rectum, but no significant difference in CRP (p = 0.44). CRP was not a predictor of overall survival (HR 0.99, 95% CI 0.98-1.01) nor cancer-specific survival in irradiated patients (HR 0.94, 95% CI 0.94-1.02). CONCLUSIONS: There was a significant negative relationship between SIR, defined as an elevated CRP, and intratumor stromal infiltration by T-regulatory FOXP3+ cells. This and the fact that all cases with a CRP > 75 mg/l had pMMR suggests that SIR and dMMR are independent entities in CRC. Indeed, the general lack of difference in CRP between cases with dMMR and pMMR may be evidence of overlap in cases with a less pronounced SIR. This investigation was supported by grants from the Cancer Research Foundation in Northern Sweden (Dnr LP 16-2131), the Nordic Cancer Union, the Sigrid Jusélius Foundation in Finland and the Finnish Cancer Foundation.